Similar Posts
Emergent and its 44.75 million dose sale of Biothrax for civilians
With respect to the 44.75 million doses of anthrax vaccine that Emergent BioSolutions (EBS) has announced it is selling to DHHS for the civilian stockpile (for the past several years), comes this curious notice from the Maryland Gazette. Perhaps not all federal bureaucrats are happy about paying a king’s ransom for an unsafe and unproven…
Seasonal influenza vaccination rates similar to last year
From Infectious Disease News. It may be that media-induced fears and intellectual arguments have ‘maxed out’ the number of Americans choosing to be vaccinated. Perhaps the only way to increase vaccine ‘demand’ in future will be through mandatory vaccinations. School mandates make vaccines a requirement for children, but so far there are no adult mandates,…
Reversible blindness in bilateral optic neruritis associated with nasal flu vaccine
Flu vaccines would be fine for everyone to take each year if the benefit exceeded the risk plus cost. The cost in a drug store to be vaccinated is about $25. No benefit can be demonstrated in those over 65 or in younger children, where 90% of flu deaths occur. (See several posts from earlier…
Lost in Transmission — FDA Drug Information That Never Reaches Clinicians
This NEJM Article points out that, although, “Drug labels are written by drug companies, then negotiated and approved by the FDA,” still, “information gets lost between FDA review and the approved label.” What often gets lost is data on harms due to the drug. Several examples are included, and it turns out that two popular…
Albania rejects request to destroy Syrian chemical weapons/ Fox
Albanians celebrate on a monument to the national hero Skanderbeg after Edi Rama rejected the US request to host the chemical weapons. Photo: Arben Celi/Reuters The UN’s Organization for the Prohibition of Chemical Weapons (OPCW) has completed its inspection work in Syria on time, and without any major hitch. All production facilities for chemical weapons have…
Is Avian Flu vaccine next for selected groups?/ WHO
WHO’s Strategic Group of Experts Working Group on Avian Flu (H5N1) Vaccine is working on “evidence-based recommendations” for using up stockpiles of avian flu vaccine that are reaching their expiration date. From WHO’s website: “Facilitate a SAGE review and decision on potential evidence-based recommendations on the use during the current inter-pandemic period of: H5N1 influenza…
One Comment
Comments are closed.
Hilarious!!